241 related articles for article (PubMed ID: 29744980)
1. An overview of take-home naloxone programs in Australia.
Dwyer R; Olsen A; Fowlie C; Gough C; van Beek I; Jauncey M; Lintzeris N; Oh G; Dicka J; Fry CL; Hayllar J; Lenton S
Drug Alcohol Rev; 2018 May; 37(4):440-449. PubMed ID: 29744980
[TBL] [Abstract][Full Text] [Related]
2. Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities.
Dietze PM; Stare M; Cogger S; Nambiar D; Olsen A; Burns L; Lenton S
Drug Alcohol Rev; 2018 May; 37(4):457-463. PubMed ID: 29744979
[TBL] [Abstract][Full Text] [Related]
3. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
[TBL] [Abstract][Full Text] [Related]
4. Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs.
Dietze PM; Draper B; Olsen A; Chronister KJ; van Beek I; Lintzeris N; Dwyer R; Nelson M; Lenton S
Drug Alcohol Rev; 2018 May; 37(4):472-479. PubMed ID: 29473245
[TBL] [Abstract][Full Text] [Related]
5. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
[TBL] [Abstract][Full Text] [Related]
6. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
McDonald R; Campbell ND; Strang J
Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
[TBL] [Abstract][Full Text] [Related]
7. Assessing causality in drug policy analyses: How useful are the Bradford Hill criteria in analysing take-home naloxone programs?
Olsen A; McDonald D; Lenton S; Dietze PM
Drug Alcohol Rev; 2018 May; 37(4):499-501. PubMed ID: 28421696
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
Sajwani HS; Williams AV
Harm Reduct J; 2022 Oct; 19(1):117. PubMed ID: 36266701
[TBL] [Abstract][Full Text] [Related]
9. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
10. The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions.
Monds LA; Bravo M; Mills L; Malcolm A; Gilliver R; Wood W; Harrod ME; Read P; Nielsen S; Dietze PM; Lenton S; Bleeker AM; Lintzeris N
Drug Alcohol Rev; 2022 Jul; 41(5):1085-1094. PubMed ID: 35442514
[TBL] [Abstract][Full Text] [Related]
11. Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.
Chronister KJ; Lintzeris N; Jackson A; Ivan M; Dietze PM; Lenton S; Kearley J; van Beek I
Drug Alcohol Rev; 2018 May; 37(4):464-471. PubMed ID: 27071354
[TBL] [Abstract][Full Text] [Related]
12. Alberta's provincial take-home naloxone program: A multi-sectoral and multi-jurisdictional response to overdose.
Freeman LK; Bourque S; Etches N; Goodison K; O'Gorman C; Rittenbach K; Sikora CA; Yarema M
Can J Public Health; 2017 Nov; 108(4):e398-e402. PubMed ID: 29120311
[TBL] [Abstract][Full Text] [Related]
13. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
[TBL] [Abstract][Full Text] [Related]
14. Exploring the life-saving potential of naloxone: A systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users.
McAuley A; Aucott L; Matheson C
Int J Drug Policy; 2015 Dec; 26(12):1183-8. PubMed ID: 26508033
[TBL] [Abstract][Full Text] [Related]
15. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
[TBL] [Abstract][Full Text] [Related]
16. Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.
Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L
Pain Med; 2018 Mar; 19(3):533-540. PubMed ID: 28340185
[TBL] [Abstract][Full Text] [Related]
17. Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people's perceptions of the BC take home naloxone program.
Mitchell K; Durante SE; Pellatt K; Richardson CG; Mathias S; Buxton JA
Harm Reduct J; 2017 Jun; 14(1):34. PubMed ID: 28592287
[TBL] [Abstract][Full Text] [Related]
18. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
19. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
[TBL] [Abstract][Full Text] [Related]
20. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
